Table of Contents Author Guidelines Submit a Manuscript
Journal of Pharmaceutics
Volume 2013, Article ID 390425, 5 pages
http://dx.doi.org/10.1155/2013/390425
Research Article

Buckysomes: New Nanocarriers for Anticancer Drugs

1Division of Cardiology, Department of Internal Medicine, The University of Texas Health Science Center at Houston, 1881 East Road, Houston, TX 77054, USA
2Biomatrica, 5627 Oberlin Drive, San Diego, CA 92121, USA
3Graduate Schools of Biomedical Sciences, The University of Texas Health Science Center at Houston, 6767 Bertner Ave, Houston, TX 77030, USA
4Department of Anesthesiology, The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 7703, USA
5Casscells & Associates, LLC, 7111 Davis Court, McLean, VA 22101, USA

Received 28 November 2012; Accepted 1 February 2013

Academic Editor: Awesh Yadav

Copyright © 2013 Delia Danila et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Spencer and D. Faulds, “Paclitaxel: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer,” Drugs, vol. 48, no. 5, pp. 794–847, 1994. View at Google Scholar · View at Scopus
  2. L. M. Han, J. Guo, L. J. Zhang, Q. S. Wang, and X. L. Fang, “Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123,” Acta Pharmacologica Sinica, vol. 27, no. 6, pp. 747–753, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. R. B. Weiss, R. C. Donehower, P. H. Wiernik et al., “Hypersensitivity reactions from taxol,” Journal of Clinical Oncology, vol. 8, no. 7, pp. 1263–1268, 1990. View at Google Scholar · View at Scopus
  4. R. T. Dorr, “Pharmacology and toxicology of Cremophor EL diluent,” The Annals of Pharmacotherapy, vol. 28, 5, pp. S11–S14, 1994. View at Google Scholar
  5. M. Ferrari, “Cancer nanotechnology: opportunities and challenges,” Nature Reviews Cancer, vol. 5, no. 3, pp. 161–171, 2005. View at Google Scholar
  6. V. P. Torchilin, “Multifunctional nanocarriers,” Advanced Drug Delivery Reviews, vol. 58, no. 14, pp. 1532–1555, 2006. View at Google Scholar
  7. P. Crosasso, M. Ceruti, P. Brusa, S. Arpicco, F. Dosio, and L. Cattel, “Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes,” Journal of Controlled Release, vol. 63, no. 1-2, pp. 19–30, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Partha, M. Lackey, A. Hirsch, S. W. Casscells, and J. L. Conyers, “Self assembly of amphiphilic C60 fullerene derivatives into nanoscale supramolecular structures,” Journal of Nanobiotechnology, vol. 5, article 6, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Partha, L. R. Mitchell, J. L. Lyon, P. P. Joshi, and J. L. Conyers, “Buckysomes: fullerene-based nanocarriers for hydrophobic molecule delivery,” ACS Nano, vol. 2, no. 9, pp. 1950–1958, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Brettreich, S. Burghardt, C. Bottcher, T. Bayerl, S. Bayerl, and A. Hirsch, “Globular amphiphiles: membrane-forming hexaaducts of C (60),” Angewandte Chemie International Edition, vol. 39, no. 10, pp. 1845–1848, 2000. View at Google Scholar